申请人:Abe Hidenori
公开号:US20060223826A1
公开(公告)日:2006-10-05
The present invention provide a compound of the formula (I) wherein ring A represents an aromatic ring optionally having substituents; B, Y and Ya are the same or different and each represents a bond, etc.; R
1
and R
2
are the same or different and each represents a hydrogen atom, etc.; R
3
represents a hydrogen atom, etc.; R
4
and R
5
are the same or different and each represents a hydrogen, etc.; R
6
represents an indolyl group optionally having substituents; and Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibition activity and is useful for preventing and/or treating diseases associated with somatostatin.
本发明提供了一种化合物(I)的公式,其中环A代表一种芳香环,可选地具有取代基; B、Y和Ya相同或不同,每个代表一种键等; R1和R2相同或不同,每个代表一个氢原子等; R3代表一个氢原子等; R4和R5相同或不同,每个代表一个氢等; R6代表一种吲哚基,可选地具有取代基; Z和Za相同或不同,每个代表一个氢原子等; 或其盐或前药,具有生长抑素受体结合抑制活性,并用于预防和/或治疗与生长抑素相关的疾病。